San Diego, CA · Founded 2020 · Privately Held (backing)
Operator of a biopharmaceutical company designed to develop treatments for oncology and autoimmune diseases. BlossomHill Therapeutics is based in San Diego, CA and was founded in 2020. It was valued at $413 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $257 million across 4 recorded rounds; the latest was an $84.2 million later-stage round in Nov 2025.
PMV mark · valuation
$413.1M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$257.1M
Last round
Later Stage VC
Nov 2025
Cap table — not yet on record
BlossomHill Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BlossomHill Therapeutics with a free account
·Watch BlossomHill Therapeutics: the Monday email on marks, rounds and moves
Where does BlossomHill Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across BlossomHill Therapeutics's 4 recorded funding rounds.
